Cite
APA Citation
Cardoso, F., Bardia, A., André, F., Cescon, D. W., McArthur, H., Telli, M., Loi, S., Cortes, J., Schmid, P., Harbeck, N., Denkert, C., Jackisch, C., Jia, L., Hirshfield, K., & Karantza, V. (n.d.). 24TiPKEYNOTE-756: A randomized, double-blind, phase III study of pembrolizumab or placebo with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk, early-stage, ER+/HER2−breast cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098038827.0x00002d